These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Actin filaments are involved in the regulation of trafficking of two closely related chemokine receptors, CXCR1 and CXCR2. Zaslaver A; Feniger-Barish R; Ben-Baruch A J Immunol; 2001 Jan; 166(2):1272-84. PubMed ID: 11145710 [TBL] [Abstract][Full Text] [Related]
24. Metalloproteinases are involved in lipopolysaccharide- and tumor necrosis factor-alpha-mediated regulation of CXCR1 and CXCR2 chemokine receptor expression. Khandaker MH; Mitchell G; Xu L; Andrews JD; Singh R; Leung H; Madrenas J; Ferguson SS; Feldman RD; Kelvin DJ Blood; 1999 Apr; 93(7):2173-85. PubMed ID: 10090924 [TBL] [Abstract][Full Text] [Related]
25. Development of a systemically-active dual CXCR1/CXCR2 allosteric inhibitor and its efficacy in a model of transient cerebral ischemia in the rat. Garau A; Bertini R; Mosca M; Bizzarri C; Anacardio R; Triulzi S; Allegretti M; Ghezzi P; Villa P Eur Cytokine Netw; 2006 Mar; 17(1):35-41. PubMed ID: 16613761 [TBL] [Abstract][Full Text] [Related]
26. Treatment with DF 2162, a non-competitive allosteric inhibitor of CXCR1/2, diminishes neutrophil influx and inflammatory hypernociception in mice. Cunha TM; Barsante MM; Guerrero AT; Verri WA; Ferreira SH; Coelho FM; Bertini R; Di Giacinto C; Allegretti M; Cunha FQ; Teixeira MM Br J Pharmacol; 2008 May; 154(2):460-70. PubMed ID: 18362895 [TBL] [Abstract][Full Text] [Related]
28. Synthesis and biological evaluation of N-pyrazolyl-N'-alkyl/benzyl/phenylureas: a new class of potent inhibitors of interleukin 8-induced neutrophil chemotaxis. Bruno O; Brullo C; Bondavalli F; Schenone S; Ranise A; Arduino N; Bertolotto MB; Montecucco F; Ottonello L; Dallegri F; Tognolini M; Ballabeni V; Bertoni S; Barocelli E J Med Chem; 2007 Jul; 50(15):3618-26. PubMed ID: 17608466 [TBL] [Abstract][Full Text] [Related]
29. Neutrophils recruited by CXCR1/2 signalling mediate post-incisional pain. Carreira EU; Carregaro V; Teixeira MM; Moriconi A; Aramini A; Verri WA; Ferreira SH; Cunha FQ; Cunha TM Eur J Pain; 2013 May; 17(5):654-63. PubMed ID: 23132735 [TBL] [Abstract][Full Text] [Related]
30. Design of noncompetitive interleukin-8 inhibitors acting on CXCR1 and CXCR2. Moriconi A; Cesta MC; Cervellera MN; Aramini A; Coniglio S; Colagioia S; Beccari AR; Bizzarri C; Cavicchia MR; Locati M; Galliera E; Di Benedetto P; Vigilante P; Bertini R; Allegretti M J Med Chem; 2007 Aug; 50(17):3984-4002. PubMed ID: 17665889 [TBL] [Abstract][Full Text] [Related]
31. The chemokine receptors CXCR1 and CXCR2 couple to distinct G protein-coupled receptor kinases to mediate and regulate leukocyte functions. Raghuwanshi SK; Su Y; Singh V; Haynes K; Richmond A; Richardson RM J Immunol; 2012 Sep; 189(6):2824-32. PubMed ID: 22869904 [TBL] [Abstract][Full Text] [Related]
32. Inhibition of LPS-induced airway neutrophilic inflammation in healthy volunteers with an oral CXCR2 antagonist. Leaker BR; Barnes PJ; O'Connor B Respir Res; 2013 Dec; 14(1):137. PubMed ID: 24341382 [TBL] [Abstract][Full Text] [Related]
33. Elucidation of Distinct Roles of Guinea Pig CXCR1 and CXCR2 in Neutrophil Migration toward IL-8 and GROα by Specific Antibodies. Tanaka K; Yoshitomi T; Hirahara K Biol Pharm Bull; 2017; 40(5):729-732. PubMed ID: 28458362 [TBL] [Abstract][Full Text] [Related]
34. Differential Interleukin-8 thresholds for chemotaxis and netosis in human neutrophils. Teijeira A; Garasa S; Ochoa MDC; Cirella A; Olivera I; Glez-Vaz J; Andueza MP; Migueliz I; Alvarez M; Rodríguez-Ruiz ME; Rouzaut A; Berraondo P; Sanmamed MF; Perez Gracia JL; Melero I Eur J Immunol; 2021 Sep; 51(9):2274-2280. PubMed ID: 33963542 [TBL] [Abstract][Full Text] [Related]
35. Decreased CXCR1 and CXCR2 expression on neutrophils in anti-neutrophil cytoplasmic autoantibody-associated vasculitides potentially increases neutrophil adhesion and impairs migration. Hu N; Westra J; Rutgers A; Doornbos-Van der Meer B; Huitema MG; Stegeman CA; Abdulahad WH; Satchell SC; Mathieson PW; Heeringa P; Kallenberg CG Arthritis Res Ther; 2011; 13(6):R201. PubMed ID: 22152684 [TBL] [Abstract][Full Text] [Related]
36. Inhibition of interleukin-8 (CXCL8/IL-8) responses by repertaxin, a new inhibitor of the chemokine receptors CXCR1 and CXCR2. Casilli F; Bianchini A; Gloaguen I; Biordi L; Alesse E; Festuccia C; Cavalieri B; Strippoli R; Cervellera MN; Di Bitondo R; Ferretti E; Mainiero F; Bizzarri C; Colotta F; Bertini R Biochem Pharmacol; 2005 Feb; 69(3):385-94. PubMed ID: 15652230 [TBL] [Abstract][Full Text] [Related]
37. Blockade of the chemokine receptor CXCR2 ameliorates adjuvant-induced arthritis in rats. Barsante MM; Cunha TM; Allegretti M; Cattani F; Policani F; Bizzarri C; Tafuri WL; Poole S; Cunha FQ; Bertini R; Teixeira MM Br J Pharmacol; 2008 Mar; 153(5):992-1002. PubMed ID: 17891165 [TBL] [Abstract][Full Text] [Related]
38. Differential modes of regulation of cxc chemokine-induced internalization and recycling of human CXCR1 and CXCR2. Feniger-Barish R; Ran M; Zaslaver A; Ben-Baruch A Cytokine; 1999 Dec; 11(12):996-1009. PubMed ID: 10623425 [TBL] [Abstract][Full Text] [Related]
39. n-butanol extract from Folium isatidis inhibits the lipopolysaccharide-induced downregulation of CXCR1 and CXCR2 on human neutrophils. Wu B; Wang L; Jiang L; Dong L; Xu F; Lu Y; Jin J; Wang Z; Liang G; Shan X Mol Med Rep; 2018 Jan; 17(1):179-185. PubMed ID: 29115434 [TBL] [Abstract][Full Text] [Related]